Literature DB >> 1971412

Induction of von Willebrand disease type I by valproic acid.

W Kreuz, R Linde, M Funk, R Meyer-Schrod, E Föll, U Nowak-Göttl, G Jacobi, Z Vigh, I Scharrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1971412     DOI： 10.1016/0140-6736(90)91235-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries.

Authors:  Sheng Chen; Haijian Wu; Damon Klebe; Yuan Hong; Jianmin Zhang
Journal:  Neurochem Res       Date:  2014-01-31       Impact factor: 3.996

Review 2.  [Perioperative coagulation diagnostics].

Authors:  C-E Dempfle
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

3.  Development and treatment of spinal deformity in patients with cerebral palsy.

Authors:  Athanasios I Tsirikos
Journal:  Indian J Orthop       Date:  2010-04       Impact factor: 1.251

Review 4.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

5.  Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature.

Authors:  Eva Jennes; Dorothee Guggenberger; Rainer Zotz; Lora Thompson; Tim H Brümmendorf; Steffen Koschmieder; Edgar Jost
Journal:  Clin Case Rep       Date:  2017-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.